Home › Funds › BAKER BROS. ADVISORS LP › RVMD

BAKER BROS. ADVISORS LP position in RVMD

REVOLUTION MEDICINES INC · Health Care

BAKER BROS. ADVISORS LP reported holding 11,443,357 shares of RVMD (REVOLUTION MEDICINES INC) in its Q2 2026 13F filing — a position valued at US$2.14B, representing 11.20% of its reported portfolio and ranking #3 among its reported holdings. BAKER BROS. ADVISORS LP has disclosed RVMD holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

Latest position (Q2 2026)11.44M sh
Reported value held$2.14B
Portfolio Weight11.20%
First reportedQ3 2023
Last changeAdd
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How BAKER BROS. ADVISORS LP's RVMD position evolved

BAKER BROS. ADVISORS LP first disclosed a stake in RVMD in Q3 2023 at 2,691,493 shares (US$74.5M). The position peaked in Q2 2026 at 11,443,357 shares, worth US$2.14B. Across 12 filings, BAKER BROS. ADVISORS LP increased the stake 7 time(s), trimmed it 0 time(s) and left it unchanged 4 time(s). The most recent filing (Q2 2026) shows 11,443,357 shares valued at US$2.14B — an increase of 1,888,000 shares quarter over quarter.. Notable position changes include a 91% increase in Q4 2023 (shares rose 12% over the following quarter), a 47% increase in Q1 2024 (shares rose 20% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 2.69M $74.50M New
Q4 2023 5.15M $147.66M Add
Q1 2024 7.55M $243.31M Add
Q2 2024 7.57M $293.76M Hold
Q3 2024 7.57M $343.26M Hold
Q4 2024 7.94M $347.16M Add
Q1 2025 7.94M $280.65M Hold
Q2 2025 9.36M $344.54M Add
Q3 2025 9.46M $441.57M Add
Q4 2025 9.46M $753.12M Hold
Q1 2026 9.56M $929.26M Add
Q2 2026 11.44M $2.14B Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About RVMD and 13F data

RVMD (REVOLUTION MEDICINES INC) is a Health Care company. 60 other funds we track also report a position in RVMD — the largest reported positions include Farallon Capital Management (US$2.54B), FARALLON CAPITAL MANAGEMENT, L.L.C. (US$2.54B), Darwin Global Management, Ltd. (US$2.05B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding RVMD

All RVMD fund holders →

FAQ

How long has BAKER BROS. ADVISORS LP held RVMD?

BAKER BROS. ADVISORS LP has disclosed RVMD holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

What is BAKER BROS. ADVISORS LP's current position in RVMD?

As of Q2 2026, BAKER BROS. ADVISORS LP holds 11.44M shares of RVMD (REVOLUTION MEDICINES INC), valued at $2.14B, representing 11.20% of its reported portfolio and ranking #3.

Has BAKER BROS. ADVISORS LP been buying or selling RVMD?

In the latest 13F filing (Q2 2026), BAKER BROS. ADVISORS LP increased its position in RVMD. The position peaked in Q2 2026 at 11.44M shares.

Which other funds hold RVMD?

Other major institutional holders of RVMD include Farallon Capital Management, FARALLON CAPITAL MANAGEMENT, L.L.C., Darwin Global Management, Ltd., among 60 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.